Using stem cell technology to combat age-related neurodegenerative diseases

Add to your list(s) Download to your calendar using vCal

• Sally Temple PhD, Scientific Director, Neural Stem Cell Institute, USA
• Tuesday 27 July 2021, 16:00-17:00
• Webinar - https://zoom.us/j/99447632193?pwd=QU9vbXliNXcvcXZqVFFBbHVpd2tSUT09.

If you have a question about this talk, please contact Scientific Meetings Co-ordinator.

We use stem cell technology to create authentic central nervous system cells valuable to combat neurodegenerative diseases. We have discovered a novel stem cell in the adult human retina that we are harnessing for cell replacement therapy in patients with age-related macular degeneration. In addition, we use cerebral organoids to study how cells change in tauopathy. Tauopathies are associated with synapse loss, neuronal and glial cell death, tau aggregation, and tau hyperphosphorylation, but which pathways lead to these neurodegenerative events are not fully resolved. Working with the Tau Consortium, we have helped establish an extensive collection of iPSC lines and isogenic controls. In a collaborative team, we have examined tau proteaforms, isoforms, turnover, histology, as well as transcriptomic changes, and revealed a timecourse of phenotypic alterations associated with tauopathy.

This talk is part of the MRC LMB Seminar Series series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Biology
• CCC talks for website
• Cambridge Immunology
• Centre for Health Leadership and Enterprise
• Liam
• Life Sciences
• Life Sciences
• ME Seminar
• MRC LMB Seminar Series
• Neurons, Fake News, DNA and your iPhone: The Mathematics of Information
• Webinar - https://zoom.us/j/99447632193?pwd=QU9vbXliNXcvcXZqVFFBbHVpd2tSUT09
• cri
• my_list
• other talks
• rc781

Note that ex-directory lists are not shown.